Westover Capital Advisors’s Elevance Health ELV Stock Holding History

Westover Capital Advisors’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-5,074	Closed	-$708K	–	94
2015 Q4	$708K	Hold	5,074	–	–	0.59%	45
2015 Q3	$710K	Hold	5,074	–	–	0.61%	48
2015 Q2	$833K	Hold	5,074	–	–	0.66%	47
2015 Q1	$783K	Sell	5,074 -178	-3%	-$25.3K	0.63%	51
2014 Q4	$660K	Sell	5,252 -48	-0.9%	-$5.93K	0.57%	53
2014 Q3	$634K	Sell	5,300 -209	-4%	-$24K	0.52%	59
2014 Q2	$593K	Hold	5,509	–	–	0.5%	58
2014 Q1	$548K	Hold	5,509	–	–	0.51%	56
2013 Q4	$509K	Buy	+5,509	New	+$490K	0.49%	53

Other funds holding ELV

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Westover Capital Advisors's ELV Position: Q1 2016 in Review

Westover Capital Advisors sold out of Elevance Health (ELV) in Q1 2016, closing a stake of 5,074 shares — an estimated $708K sold.

Westover Capital Advisors first reported a position in ELV in Q4 2013 and held it in 9 quarters. The position peaked at $833K in Q2 2015. 771 funds tracked by Wall St. Rank hold ELV as of Q1 2016.

Westover Capital Advisors reported no remaining Elevance Health position as of Q1 2016 after selling out during the quarter.
Westover Capital Advisors sold 5,074 Elevance Health shares in Q1 2016, an estimated $708K.
Westover Capital Advisors first reported a position in Elevance Health in Q4 2013 and held it in 9 quarters.
Westover Capital Advisors's Elevance Health position peaked at $833K in Q2 2015.
771 funds tracked by Wall St. Rank held Elevance Health as of Q1 2016.

Based on Westover Capital Advisors's 13F filing for Q1 2016, filed 13 May 2016.